Immunomedics, Mallinckrodt Group Inc. sales and marketing update

Mallinckrodt began selling CEA-Scan (arcitumomab), IMMU's imaging agent for diagnosing colorectal cancer. Price was not disclosed. The FDA approved the product in June to detect the presence, locatio...